RCUS

Arcus Biosciences (RCUS)

Arcus Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:RCUS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/03	21:18	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RCUS	Arcus Biosciences Inc
2024/06/02	21:00	Business Wire	Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer	NYSE:RCUS	Arcus Biosciences Inc
2024/06/02	21:00	Business Wire	Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer	NYSE:RCUS	Arcus Biosciences Inc
2024/06/01	21:00	Business Wire	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers	NYSE:RCUS	Arcus Biosciences Inc
2024/06/01	21:00	Business Wire	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers	NYSE:RCUS	Arcus Biosciences Inc
2024/05/25	05:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/05/24	05:59	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RCUS	Arcus Biosciences Inc
2024/05/10	05:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/05/09	05:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:RCUS	Arcus Biosciences Inc
2024/05/09	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RCUS	Arcus Biosciences Inc
2024/05/09	05:02	Business Wire	Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update	NYSE:RCUS	Arcus Biosciences Inc
2024/05/03	05:05	Business Wire	Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024	NYSE:RCUS	Arcus Biosciences Inc
2024/04/25	05:00	Business Wire	Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting	NYSE:RCUS	Arcus Biosciences Inc
2024/04/24	05:05	Business Wire	Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update	NYSE:RCUS	Arcus Biosciences Inc
2024/04/10	05:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/03/27	05:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/03/12	05:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/02/29	06:05	Business Wire	Arcus Biosciences to Participate in Two Upcoming Investor Conferences	NYSE:RCUS	Arcus Biosciences Inc
2024/02/28	06:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/02/22	06:53	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NYSE:RCUS	Arcus Biosciences Inc
2024/02/22	06:32	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:RCUS	Arcus Biosciences Inc
2024/02/22	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RCUS	Arcus Biosciences Inc
2024/02/22	06:05	Business Wire	Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update	NYSE:RCUS	Arcus Biosciences Inc
2024/02/10	06:35	Business Wire	Arcus Biosciences Announces New Employment Inducement Grants	NYSE:RCUS	Arcus Biosciences Inc
2024/02/08	08:58	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:RCUS	Arcus Biosciences Inc
2024/02/08	07:00	Business Wire	Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates	NYSE:RCUS	Arcus Biosciences Inc
2024/01/30	22:17	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RCUS	Arcus Biosciences Inc
2024/01/30	20:25	IH Market News	Arcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More News	NYSE:RCUS	Arcus Biosciences Inc
2024/01/30	07:00	Business Wire	Gilead and Arcus Announce Amended Collaboration and Equity Investment	NYSE:RCUS	Arcus Biosciences Inc
2024/01/30	07:00	Business Wire	Gilead and Arcus Announce Amended Collaboration and Equity Investment	NYSE:RCUS	Arcus Biosciences Inc